» Articles » PMID: 26237488

Fetal Cell Based Prenatal Diagnosis: Perspectives on the Present and Future

Overview
Journal J Clin Med
Specialty General Medicine
Date 2015 Aug 4
PMID 26237488
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The ability to capture and analyze fetal cells from maternal circulation or other sources during pregnancy has been a goal of prenatal diagnostics for over thirty years. The vision of replacing invasive prenatal diagnostic procedures with the prospect of having the entire fetal genome in hand non-invasively for chromosomal and molecular studies for both clinical and research use has brought many investigators and innovations into the effort. While the object of this desire, however, has remained elusive, the aspiration for this approach to non-invasive prenatal diagnosis remains and the inquiry has continued. With the advent of screening by cell-free DNA analysis, the standards for fetal cell based prenatal diagnostics have been sharpened. Relevant aspects of the history and the current status of investigations to meet the goal of having an accessible and reliable strategy for capturing and analyzing fetal cells during pregnancy are reviewed.

Citing Articles

Recent Advances of Microfluidic Platform for Cell Based Non-Invasive Prenatal Diagnosis.

Jou H, Lo P, Ling P Int J Mol Sci. 2023; 24(2).

PMID: 36674508 PMC: 9865170. DOI: 10.3390/ijms24020991.


Enrichment of circulating trophoblasts from maternal blood using filtration-based Metacell® technology.

Weymaere J, Vander Plaetsen A, Van Den Branden Y, Pospisilova E, Tytgat O, Deforce D PLoS One. 2022; 17(7):e0271226.

PMID: 35834570 PMC: 9282611. DOI: 10.1371/journal.pone.0271226.


Novel Approaches to an Integrated Route for Trisomy 21 Evaluation.

Buczynska A, Sidorkiewicz I, Trochimiuk A, Lawicki S, Kretowski A, Zbucka-Kretowska M Biomolecules. 2021; 11(9).

PMID: 34572541 PMC: 8465311. DOI: 10.3390/biom11091328.


Single-Cell Microwell Platform Reveals Circulating Neural Cells as a Clinical Indicator for Patients with Blood-Brain Barrier Breakdown.

Zhang Y, Warden A, Ahmad K, Liu Y, He X, Zheng M Research (Wash D C). 2021; 2021:9873545.

PMID: 34327332 PMC: 8285994. DOI: 10.34133/2021/9873545.


Development of a Specific Monoclonal Antibody to Detect Male Cells Expressing the RPS4Y1 Protein.

Spena S, Cordiglieri C, Garagiola I, Peyvandi F Int J Mol Sci. 2021; 22(4).

PMID: 33670450 PMC: 7921920. DOI: 10.3390/ijms22042001.


References
1.
Babochkina T, Mergenthaler S, De Napoli G, Hristoskova S, Tercanli S, Holzgreve W . Numerous erythroblasts in maternal blood are impervious to fluorescent in situ hybridization analysis, a feature related to a dense compact nucleus with apoptotic character. Haematologica. 2005; 90(6):740-5. View

2.
Schueler P, Yamanishi D, Collarini E, Pearson J, Lee Y, Cain C . Enrichment and identification of fetal trophoblast cells from first trimester maternal cervical lavage and uterine blood specimens. Placenta. 2001; 22(8-9):688-701. DOI: 10.1053/plac.2001.0705. View

3.
Bianchi D, Hanson J . Sharpening the tools: a summary of a National Institutes of Health workshop on new technologies for detection of fetal cells in maternal blood for early prenatal diagnosis. J Matern Fetal Neonatal Med. 2006; 19(4):199-207. DOI: 10.1080/14767050600676851. View

4.
Mouawia H, Saker A, Jais J, Benachi A, Bussieres L, Lacour B . Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy. Reprod Biomed Online. 2012; 25(5):508-20. DOI: 10.1016/j.rbmo.2012.08.002. View

5.
Futch T, Spinosa J, Bhatt S, de Feo E, Rava R, Sehnert A . Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn. 2013; 33(6):569-74. PMC: 3709117. DOI: 10.1002/pd.4123. View